OPALEYE MANAGEMENT INC. – Crinetics Pharmaceuticals, Inc. Transaction History
OPALEYE MANAGEMENT INC. portfolio value:
$13.18M
portfolio value
OPALEYE MANAGEMENT INC. quarter portfolio value change:
+5.31%
quarter
Crinetics Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 664K | $19.64 | 671.3K | |
| Q2 2022 | share | Decrease | -3.13% | -21.7K shares | -2.69M | $18.65 | 671.3K |
| Q1 2022 | share | Decrease | -4.33% | -31.4K shares | -5.36M | $21.95 | 693K |
| Q4 2021 | share | Increase | +80.15% | 322.28K shares | 12.11M | $28.03 | 724.4K |
| Q3 2021 | share | Increase | +100.56% | 201.61K shares | 4.68M | $21.05 | 402.11K |
| Q2 2021 | share | Increase | +6.65% | 12.5K shares | 906K | $18.85 | 200.5K |
| Q1 2021 | share | Increase | 0.00% | 188K shares | 2.87M | $15.28 | 188K |
| Q4 2020 | share | Decrease | -100.00% | -240K shares | -3.76M | $14.11 | 0 |
| Q3 2020 | share | Decrease | -44.85% | -195.2K shares | -3.86M | $15.67 | 240K |
| Q2 2020 | share | Increase | +18.02% | 66.45K shares | 2.20M | $17.52 | 435.2K |
| Q1 2020 | share | Increase | +38.58% | 102.65K shares | -1.25M | $14.7 | 368.75K |
| Q4 2019 | share | Increase | +28.55% | 59.1K shares | 3.56M | $25.09 | 266.1K |
| Q3 2019 | share | Increase | +475.00% | 171K shares | 2.21M | $15.04 | 207K |
| Q2 2019 | share | Decrease | -50.68% | -37K shares | -761K | $25 | 36K |
| Q1 2019 | share | Increase | 0.00% | 73K shares | 1.66M | $22.76 | 73K |